The bill amends various sections of the Washington state law regarding the Andy Hill cancer research endowment, specifically RCW 43.348.010, 43.348.020, 43.348.040, 43.348.060, and 43.348.080. Key changes include the introduction of new definitions such as "clinical trial," which is defined as a cancer clinical trial, and the clarification of the roles and responsibilities of the program administrator. The bill also emphasizes the need for the board to be staffed by one or more program administrators selected under contract, and it allows for the creation of tax-exempt nonprofit corporations to assist in fulfilling these duties. Additionally, the bill mandates that the endowment must issue an annual report detailing its activities, including grants awarded and research accomplishments.

Furthermore, the bill modifies the funding structure of the Andy Hill cancer research endowment fund match transfer account, specifying that state matching funds and other appropriations will be used exclusively for the program. It establishes that expenditures from this account will only occur upon proof of committed nonstate or private contributions for cancer research, prevention, or care. The bill also includes provisions to ensure that grant funding processes are not subject to certain requirements, thereby streamlining the allocation of resources for cancer research initiatives in Washington state.

Statutes affected:
Original Bill: 43.348.020, 43.348.040, 43.348.060, 43.348.080
Bill as Passed Legislature: 43.348.020, 43.348.040, 43.348.060, 43.348.080
Session Law: 43.348.020, 43.348.040, 43.348.060, 43.348.080